Last reviewed · How we verify
Nasal Povidone Iodine
At a glance
| Generic name | Nasal Povidone Iodine |
|---|---|
| Also known as | Povidone Iodine |
| Sponsor | VA Office of Research and Development |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Povidone-Iodine Nasal Irrigation After Surgery for Chronic Rhinosinusitis (NA)
- PVI to Prevent S. Aureus SSI After Fixation of HELEF (POTENT Study) (PHASE4)
- Effectiveness of Screening and Decolonization of S. Aureus to Prevent S. Aureus Surgical Site Infections in Surgery Outpatients
- Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients (PHASE2)
- Nasal Antisepsis for C. Auris Prevention (PHASE4)
- Surgical Wound Infection Prevention Bundle in Patients Undergoing Coronary Bypass Graft Surgery (NA)
- Mupirocin-Iodophor ICU Decolonization Swap Out Trial (PHASE4)
- Use of Particulate Cortico- Cancellous Anterior Iliac Graft with Periosteum Membrane in Unilateral Alveolar Cleft Grafting Versus Particulate Cortico-cancellous Anterior Iliac Grafting Alone. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Nasal Povidone Iodine CI brief — competitive landscape report
- Nasal Povidone Iodine updates RSS · CI watch RSS
- VA Office of Research and Development portfolio CI